trending Market Intelligence /marketintelligence/en/news-insights/trending/GpreOPDiaTcZEvhXIsF9tQ2 content esgSubNav
In This List

Yifeng Pharmacy Chain Q3 profit climbs 25.4% YOY

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Earnings forecasts for US banks; corporate deleveraging; LatAm currency gains

Blog

Insight Weekly: M&A slows down; climate tops proxy season; private equity pours into blockchain


Yifeng Pharmacy Chain Q3 profit climbs 25.4% YOY

Yifeng Pharmacy Chain Co. Ltd. said its third-quarter normalized net income amounted to 12 fen per share, a gain from 11 fen per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 40.5 million yuan, a gain of 25.4% from 32.3 million yuan in the year-earlier period.

The normalized profit margin fell to 4.5% from 4.8% in the year-earlier period.

Total revenue grew 34.7% on an annual basis to 909.8 million yuan from 675.6 million yuan, and total operating expenses climbed 34.5% year over year to 851.0 million yuan from 632.9 million yuan.

Reported net income rose 26.4% from the prior-year period to 47.3 million yuan, or 14 fen per share, from 37.4 million yuan, or 13 fen per share.

As of Oct. 28, US$1 was equivalent to 6.78 yuan.